NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

seekinganswers,

No, not really. This is a cell therapy with complex manufacturing, that has had difficulty with supply chain and product release issues that have been overcome but also is facing openly shared safety concerns (not issues) by regulators because of open processes that they prefer to be fully closed. Time helps address those concerns. In my opinion the question is whether or not both MHRA and NWBO have had enough time with no issues created by artisan or a closed system plan moving forward to adequately address their concerns. Best wishes.